| Unique ID issued by UMIN | UMIN000062769 |
|---|---|
| Receipt number | R000071864 |
| Scientific Title | A Study to Investigate Nicotine Pharmacokinetics Following Use of PA in Healthy Adults Who Smoke Combustible Cigarettes |
| Date of disclosure of the study information | 2026/09/11 |
| Last modified on | 2026/09/01 17:56:56 |
A Study to Investigate Nicotine Pharmacokinetics Following Use of PA in Healthy Adults Who Smoke Combustible Cigarettes
A Study to Investigate Nicotine Pharmacokinetics Following Use of PA in Healthy Adults Who Smoke Combustible Cigarettes
A Study to Investigate Nicotine Pharmacokinetics Following Use of PA in Healthy Adults Who Smoke Combustible Cigarettes
A Study to Investigate Nicotine Pharmacokinetics Following Use of PA in Healthy Adults Who Smoke Combustible Cigarettes
| Japan |
Smokers
| Not applicable |
Others
NO
The objective of this single-center, randomized, open-label, crossover study is to investigate nicotine pharmacokinetics following use of PA in healthy adults who smoke combustible cigarettes under confined conditions, using combustible cigarettes as comparators.
Others
The objective of this single-center, randomized, open-label, crossover study is to investigate nicotine pharmacokinetics following use of PA in healthy adults who smoke combustible cigarettes under confined conditions, using combustible cigarettes as comparators.
Plasma nicotine concentration profiles and nicotine pharmacokinetic parameters
Interventional
Cross-over
Randomized
Individual
Open -no one is blinded
No treatment
4
Prevention
| Food |
[Non-menthol smokers] Use of non-menthol flavor cigarette (Day1) - Use of non-menthol flavor PA (Day2)
[Non-menthol smokers] Use of non-menthol flavor PA (Day1) - Use of non-menthol flavor cigarette (Day2)
[Menthol smokers] Use of menthol flavor cigarette (Day1) - Use of menthol flavor PA (Day2)
[Menthol smokers] Use of menthol flavor PA (Day1) - Use of menthol flavor cigarette (Day2)
| 21 | years-old | <= |
| 65 | years-old | > |
Male and Female
-Individuals who have smoked commercial combustible cigarettes for 1 year or more and have a positive urine cotinine test at screening
-Individuals who are judged by the investigator to be in good health on the basis of the results of clinical assessments performed by the start of the investigation period on Day1
-Individuals who are willing to participate in the study, understand the informed consent document, and provide written or electronic informed consent, etc.
-Individuals who have regularly used any tobacco products other than commercial combustible cigarettes within 4 weeks prior to Day 1
-Females who are or may be pregnant, or who are lactating
-Individuals who are employees of the tobacco industry or any other parties involved in the study, etc.
40
| 1st name | Naoki |
| Middle name | |
| Last name | Miura |
JAPAN TOBACCO INC.
Scientific and Regulatory Affairs, Tobacco Business
105-6927
Kamiyacho Trust tower, 4-1-1, Toranomon, Minato-Ku, Tokyo
080-8131-5689
naoki.miura@jt.com
| 1st name | Takuya |
| Middle name | |
| Last name | Suzuki |
JAPAN TOBACCO INC.
Scientific and Regulatory Affairs, Tobacco Business
105-6927
Kamiyacho Trust tower, 4-1-1, Toranomon, Minato-Ku, Tokyo
080-2044-4311
takuya.a.suzuki@jt.com
JAPAN TOBACCO INC.
None
Self funding
Hakata Clinic Institutional Review Board
6-18, Tenyamachi, hakata-ku, Fukuoka-shi, Fukuoka prefecture
092-283-7701
hakataclinic-irb@lta-med.com
NO
| 2026 | Year | 09 | Month | 11 | Day |
Unpublished
Preinitiation
| 2026 | Year | 08 | Month | 12 | Day |
| 2026 | Year | 09 | Month | 24 | Day |
| 2026 | Year | 11 | Month | 06 | Day |
| 2026 | Year | 09 | Month | 01 | Day |
| 2026 | Year | 09 | Month | 01 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000071864